Quarterly report pursuant to Section 13 or 15(d)

Reportable Segments (Tables)

v3.20.1
Reportable Segments (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Reconciliation of Revenue from Reportable Segments to Consolidated
Summarized financial information for the Company’s reportable segments is shown in the following table:
Three months ended
March 31,
2020 2019
Sales:
Refining Services $ 100,690    $ 105,844   
Catalysts(1)
24,864    15,866   
Performance Materials 65,569    61,089   
Performance Chemicals 174,279    180,462   
Eliminations(2)
(3,804)   (4,040)  
Total $ 361,598    $ 359,221   
 Segment Adjusted EBITDA:(3)
Refining Services
$ 37,183    $ 39,731   
Catalysts(4)
22,667    18,127   
Performance Materials
13,507    10,515   
Performance Chemicals
40,474    42,673   
 Total Segment Adjusted EBITDA(5)
$ 113,831    $ 111,046   

(1) Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 10 to these condensed consolidated financial statements for further information). The proportionate share of sales is $32,291 and $29,478 for the three months ended March 31, 2020 and 2019, respectively.
(2)  The Company eliminates intersegment sales when reconciling to the Company’s condensed consolidated statements of income.
(3) The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.
(4)  The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $13,725 for the three months ended March 31, 2020, which includes $8,317 of equity in net income plus $1,658 of amortization of investment in affiliate step-up and $3,750 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $8,357 for the three months ended March 31, 2019, which includes $2,036 of equity in net income plus $2,558 of amortization of investment in affiliate step-up and $3,763 of joint venture depreciation, amortization and interest.
(5)  Total Segment Adjusted EBITDA differs from the Company’s consolidated Adjusted EBITDA due to unallocated corporate expenses.
Reconciliation of Net Income to Segment Adjusted EBITDA
A reconciliation of net income attributable to PQ Group Holdings to Segment Adjusted EBITDA is as follows:
Three months ended
March 31,
2020 2019
Reconciliation of net income attributable to PQ Group Holdings Inc. to Segment Adjusted EBITDA
Net income attributable to PQ Group Holdings Inc. $ 224    $ 3,151   
Provision for income taxes 1,427    2,447   
Interest expense, net 24,455    28,618   
Depreciation and amortization 45,670    45,894   
Segment EBITDA 71,776    80,110   
Joint venture depreciation, amortization and interest 3,750    3,763   
Amortization of investment in affiliate step-up 1,658    2,558   
Debt extinguishment costs 2,513    —   
Net loss on asset disposals 9,420    820   
Foreign currency exchange (gain) loss 3,337    (2,689)  
LIFO expense (329)   10,158   
Transaction and other related costs 2,062    80   
Equity-based compensation 5,920    3,400   
Restructuring, integration and business optimization expenses 2,030    732   
Defined benefit pension plan (benefit) cost (249)   993   
Other 1,256    1,116   
Adjusted EBITDA 103,144    101,041   
Unallocated corporate expenses 10,687    10,005   
Segment Adjusted EBITDA $ 113,831    $ 111,046